Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus
Exosome-like vesicles (ELVs), the smallest class of extracellular vesicles released from cells, function in cellular crosstalk and therefore profoundly affect physiologic responses and pathologic progression. A growing body of evidence supports a novel role for ELVs as important mediators and therap...
Saved in:
Main Authors: | Qian Ge, Xin Xin Xie, Xiaoqiu Xiao, Xi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/3256060 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
by: Ju-El Kim, et al.
Published: (2025-01-01) -
Exosomes and Their Therapeutic Potentials of Stem Cells
by: Chao Han, et al.
Published: (2016-01-01) -
Spatiotemporal Regulators for Insulin-Stimulated GLUT4 Vesicle Exocytosis
by: Xiaoxu Zhou, et al.
Published: (2017-01-01) -
Exosomes in Oral Diseases: Mechanisms and Therapeutic Applications
by: Miao Q, et al.
Published: (2025-01-01) -
Pathogenic and therapeutic roles of extracellular vesicles in sepsis
by: Benshuai You, et al.
Published: (2025-02-01)